We are live on
!
Find out more
SCM
Silverarc Capital Management Portfolio holdings
AUM
$849M
1-Year Est. Return
470.8%
This Fund
S&P 500
This Quarter
Est. Return
+21.94%
1 Year Est. Return
+470.8%
3 Year Est. Return
+3,352.06%
5 Year Est. Return
+7,957.7%
10 Year Est. Return
–
AUM
$489M
AUM Growth
+$9.97M
(+2.1%)
Cap. Flow
-$63.4M
Cap. Flow
% of AUM
-12.98%
Top 10 Holdings %
Top 10 Hldgs %
54.97%
Holding
83
New
12
Increased
18
Reduced
24
Closed
22
Top Buys
| 1 |
CG Oncology
CGON
|
+$13M |
| 2 |
Scholar Rock
SRRK
|
+$10.7M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$10.4M |
| 4 |
Vaxcyte
PCVX
|
+$9.43M |
| 5 |
Pfizer
PFE
|
+$8.03M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$14.9M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$13.9M |
| 3 |
Disc Medicine
IRON
|
+$11.7M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$9.97M |
| 5 |
Wave Life Sciences
WVE
|
+$8.49M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRUS
1
DELISTED
Merus
MRUS
| $39M | 7.99% |
741,972
-69,049
| -9% | -$3.25M |
|
|
AKRO
2
DELISTED
Akero Therapeutics
AKRO
| $38.1M | 7.8% |
713,811
-6,181
| -0.9% | -$281K |
|
|
VRNA
3
DELISTED
Verona Pharma
VRNA
| $33.9M | 6.94% |
358,297
-187,575
| -34% | -$13.9M |
|
4
UroGen Pharma
URGN
$1.94B
| $27.7M | 5.67% |
2,022,482
+641,324
| +46% | +$6.15M |
|
5
Rhythm Pharmaceuticals
RYTM
$7.52B
| $25.3M | 5.18% |
400,772
+63,167
| +19% | +$3.87M |
|
6
Insmed
INSM
$23.8B
| $25.1M | 5.13% |
249,060
-72,306
| -22% | -$5.53M |
|
|
KALV
7
DELISTED
KalVista Pharmaceuticals
KALV
| $20.7M | 4.24% |
1,832,171
+133,187
| +8% | +$1.63M |
|
|
8
Neurocrine Biosciences
NBIX
$17.3B
| $20.5M | 4.19% |
162,969
+90,386
| +125% | +$10.4M |
|
|
ETNB
9
DELISTED
89bio
ETNB
| $20M | 4.09% |
2,037,087
+526,589
| +35% | +$4.36M |
|
10
Oric Pharmaceuticals
ORIC
$1.15B
| $18.3M | 3.74% |
1,800,829
-259,411
| -13% | -$1.74M |
|
|
11
Nuvalent
NUVL
$9.81B
| $18M | 3.68% |
235,583
-203,435
| -46% | -$14.9M |
|
|
SLNO
12
DELISTED
Soleno Therapeutics
SLNO
| $17.1M | 3.51% |
204,591
+38,174
| +23% | +$2.86M |
|
13
Ascendis Pharma A/S
ASND
$17.6B
| $14.9M | 3.06% |
86,552
+10,801
| +14% | +$1.76M |
|
|
14
CG Oncology
CGON
$6.44B
| $14.1M | 2.88% |
+541,034
| New | +$13M |
|
15
Veracyte
VCYT
$4.75B
| $12.1M | 2.48% |
448,495
-185,337
| -29% | -$5.37M |
|
|
16
Scholar Rock
SRRK
$6.48B
| $12.1M | 2.47% |
+341,010
| New | +$10.7M |
|
|
RNAM
17
DELISTED
Avidity Biosciences
RNAM
| $11.6M | 2.38% |
410,000
-1,312
| -0.3% | -$39.1K |
|
|
18
Vaxcyte
PCVX
$8.19B
| $9.36M | 1.91% |
+287,796
| New | +$9.43M |
|
|
19
Pfizer
PFE
$141B
| $8.35M | 1.71% |
+344,338
| New | +$8.03M |
|
|
BBOT
20
BridgeBio Oncology
BBOT
$674M
| $6.51M | 1.33% |
613,393
| – | – |
|
21
Gossamer Bio
GOSS
$79M
| $6.33M | 1.3% |
5,146,782
-1,173,902
| -19% | -$1.28M |
|
|
MTSR
22
DELISTED
Metsera Inc
MTSR
| $5.91M | 1.21% |
207,581
+94,822
| +84% | +$2.35M |
|
23
Elutia
ELUT
$42.4M
| $5.47M | 1.12% |
2,761,684
+91,628
| +3% | +$185K |
|
24
Compugen
CGEN
$223M
| $5.4M | 1.11% |
3,033,879
+138,449
| +5% | +$205K |
|
25
TELA Bio
TELA
$35.2M
| $5.39M | 1.1% |
2,779,795
+8,507
| +0.3% | +$11.1K |
|
Similar funds
BOTOTLSJU
LA
EPIMS
CFP
USAA
OMC
AIA
EBSAM